Dynamic Contrast Enhanced MRI in Prostate Cancer

Eur J Radiol. 2007 Sep;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. Epub 2007 Aug 8.

Abstract

Angiogenesis is an integral part of benign prostatic hyperplasia (BPH), is associated with prostatic intraepithelial neoplasia (PIN) and is key to the growth and for metastasis of prostate cancer. Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) using small molecular weight gadolinium chelates enables non-invasive imaging characterization of tissue vascularity. Depending on the technique used, data reflecting tissue perfusion, microvessel permeability surface area product, and extracellular leakage space can be obtained. Two dynamic MRI techniques (T2*-weighted or susceptibility based and T1-weighted or relaxivity enhanced methods) for prostate gland evaluations are discussed in this review with reference to biological basis of observations, data acquisition and analysis methods, technical limitations and validation. Established clinical roles of T1-weighted imaging evaluations will be discussed including lesion detection and localisation, for tumour staging and for the detection of suspected tumour recurrence. Limitations include inadequate lesion characterisation particularly differentiating prostatitis from cancer, and in distinguishing between BPH and central gland tumours.

Publication types

  • Review

MeSH terms

  • Contrast Media*
  • Diagnosis, Differential
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Neoplasm Recurrence, Local / diagnosis
  • Neovascularization, Pathologic / diagnosis*
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / surgery
  • Radiotherapy Planning, Computer-Assisted

Substances

  • Contrast Media
  • Prostate-Specific Antigen